Picture of MindMaze Therapeutics Holding SA logo

MMTX MindMaze Therapeutics Holding SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Swiss stocks - Factors to watch on January 6

ZURICH/BERLIN, Jan 6 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
    
    UBS GROUP  UBSG.S  
    UBS Group will split its 2,500 Hong Kong workforce into two
groups with each returning to the workplace on alternate weeks,
as the city tightens curbs amid a spike in COVID-19 cases,
according to an internal memo to staff seen by Reuters.
 urn:newsml:reuters.com:*:nL1N2TM01N
    
    SYGNUM
    The digital asset group with a Swiss banking license and a
Singapore asset management licence has raised $90 million in a
funding round that values the group at around $800 million, it
said on Thursday  urn:newsml:reuters.com:*:nL1N2TM09N
    
    COMPANY STATEMENTS
    * Novartis AG  NOVN.S : announces collaboration with Alnylam
 ALNY.O  to explore targeted therapy to restore liver function
 NOVN.S 
    * Relief Therapeutics Holding SA  RLFB.S : reports U.S.
collaboration partner announces submission to FDA seeking EUA
for aviptadil for patients at immediate risk of death from
COVID-19 despite treatment with remdesivir, other approved
therapies  RLFB.S 
    * Obseva SA  OBSN.S : announces positive top-line results
for Linzagolix 200 mg with add-back therapy in the phase 3 trial
in patients with moderate-to-severe endometriosis-associated
pain  OBSN.S 
    * Basilea Pharmaceutica AG  BSLN.S : achieved important
Cresemba (isavuconazole) and Zevtera (ceftobiprole) milestones
in 2021  BSLN.S 
    * Baloise Holding AG  BALN.S : CEO Gert De Winter will be
stepping back from his frontline duties, probably until into
summer of 2022, so that he can focus on his cancer treatment
 BALN.S 
      
    ANALYSTS' VIEWS
    UBS GROUP AG  UBSG.S : JEFFERIES RAISES TARGET PRICE TO CHF
23 FROM CHF 22
    CREDIT SUISSE GROUP AG  CSGN.S : JP MORGAN RAISES TARGET
PRICE TO CHF 10.6 FROM CHF 10.4
    UBS GROUP AG  UBSG.S : JP MORGAN RAISES TARGET PRICE TO CHF
22 FROM CHF 21
    IDORSIA LTD  IDIA.S : CITIGROUP RAISES PRICE TARGET TO CHF
24 FROM CHF 23

    ECONOMY
    No major Swiss economic data scheduled

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on MindMaze Therapeutics Holding SA

See all news